Related references
Note: Only part of the references are listed.Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L. Tan et al.
ANNALS OF ONCOLOGY (2019)
Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients
Silvia Galbiati et al.
CLINICA CHIMICA ACTA (2019)
Hormetic Neurobehavioral effects of low dose toxic chemical mixtures in real-life risk simulation (RLRS) in rats
Aristidis M. Tsatsakis et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Combining 18F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis
Lei Zhang et al.
MOLECULAR CANCER (2019)
Prognostic significance of deregulated microRNAs in uveal melanomas
Luca Falzone et al.
MOLECULAR MEDICINE REPORTS (2019)
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
Young Kwang Chae et al.
ONCOLOGIST (2019)
Exosomes: biogenesis, biologic function and clinical potential
Yuan Zhang et al.
CELL AND BIOSCIENCE (2019)
KCNMA1 Expression Is Downregulated in Colorectal Cancer via Epigenetic Mechanisms
Maria Sofia Basile et al.
CANCERS (2019)
Life and death of circulating cell-free DNA
Anatoli Kustanovich et al.
CANCER BIOLOGY & THERAPY (2019)
TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing
Hakan Savli et al.
JOURNAL OF BIOTECHNOLOGY (2019)
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
Marie-Lisa Eich et al.
MODERN PATHOLOGY (2019)
Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
Ning Jia et al.
FRONTIERS IN GENETICS (2019)
Identification of Novel MicroRNAs and Their Diagnostic and Prognostic Significance in Oral Cancer
Luca Falzone et al.
CANCERS (2019)
Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
Jeeyun Lee et al.
FRONTIERS IN ONCOLOGY (2019)
Inflammation and Metabolism in Cancer Cell-Mitochondria Key Player
Monica Neagu et al.
FRONTIERS IN ONCOLOGY (2019)
PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
Eleni Tzanikou et al.
MOLECULAR ONCOLOGY (2019)
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Maria Cristina Petralia et al.
MOLECULES (2019)
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease
Saverio Candido et al.
ONCOLOGY REPORTS (2019)
Discovery of potent telomerase activators: Unfolding new therapeutic and anti-aging perspectives
Dimitris Tsoukalas et al.
MOLECULAR MEDICINE REPORTS (2019)
Adverse and hormetic effects in rats exposed for 12 months to low dose mixture of 13 chemicals: RLRS part III
Anca Oana Docea et al.
TOXICOLOGY LETTERS (2019)
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
Barbara Pardini et al.
CANCERS (2019)
Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
Artemiy S. Silantyev et al.
CELLS (2019)
How liquid biopsies can change clinical practice in oncology
G. Siravegna et al.
ANNALS OF ONCOLOGY (2019)
Genotoxic, cytotoxic, and cytopathological effects in rats exposed for 18 months to a mixture of 13 chemicals in doses below NOAEL levels
Aristidis Tsatsakis et al.
TOXICOLOGY LETTERS (2019)
Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer
Weirong Chen et al.
CLINICAL BREAST CANCER (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
Lydia Giannopoulou et al.
TRANSLATIONAL RESEARCH (2019)
Effect of systemic treatment on the micronuclei frequency in the peripheral blood of patients with metastatic colorectal cancer
Taxiarchis Konstantinos Nikolouzakis et al.
ONCOLOGY LETTERS (2019)
Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluid
R. Battaglia et al.
SCIENTIFIC REPORTS (2019)
Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
Hiroki Osumi et al.
CANCER MEDICINE (2019)
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Silvia Vivarelli et al.
CANCERS (2019)
Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic
Pooja Ghatalia et al.
FRONTIERS IN ONCOLOGY (2019)
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)
Wenhua Liang et al.
THERANOSTICS (2019)
Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective
Mathilde Postel et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma
Tara C. Gangadhar et al.
PIGMENT CELL & MELANOMA RESEARCH (2018)
Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development
Luca Falzone et al.
AGING-US (2018)
Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
Toshiyuki Ishiba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Ashleigh C. McEvoy et al.
BMC CANCER (2018)
Cancer Screening in the United States, 2018: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Liquid Biopsies and Cancer Immunotherapy
Jonathan R. Thompson et al.
CANCER JOURNAL (2018)
The Role of Circulating Tumor DNA in Renal Cell Carcinoma
Paulo G. Bergerot et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
Eleonora Bonaparte et al.
DIAGNOSTIC PATHOLOGY (2018)
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer
Dana Wai Yi Tsui et al.
EMBO MOLECULAR MEDICINE (2018)
Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy
Giselle Faria et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cutaneous melanoma: From pathogenesis to therapy (Review)
Giulia C. Leonardi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2018)
Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review)
Taxiarchis Konstantinos Nikolouzakis et al.
ONCOLOGY REPORTS (2018)
'Liquid biopsy' for cancer promises early detection Combining DNA and protein markers brings researchers closer to a universal cancer screening test
Jocelyn Kaiser
SCIENCE (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
Mario Presti et al.
ONCOLOGY LETTERS (2018)
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Matti Annala et al.
CANCER DISCOVERY (2018)
Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer
Yuji Takayama et al.
Oncotarget (2018)
Role of circulating tumor DNA in the management of early-stage lung cancer
Heng Zhao et al.
THORACIC CANCER (2018)
Advances in liquid biopsy approaches for early detection and monitoring of cancer
Anna Babayan et al.
GENOME MEDICINE (2018)
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Simeon U. Springer et al.
ELIFE (2018)
Liquid biopsy for early stage lung cancer
Wenhua Liang et al.
JOURNAL OF THORACIC DISEASE (2018)
Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA
Rui Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
A. K. Krug et al.
ANNALS OF ONCOLOGY (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
Alessia Finotti et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
Maria Sofia Basile et al.
MOLECULES (2018)
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
Ni Ni Moe Myint et al.
CELL DEATH & DISEASE (2018)
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Lise Barlebo Ahlborn et al.
Oncotarget (2018)
MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA
Rossella Salemi et al.
FRONTIERS IN PHARMACOLOGY (2018)
Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction
Emmanuel Gabriel et al.
FRONTIERS IN ONCOLOGY (2018)
Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients
Francesco Damin et al.
PLOS ONE (2018)
Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR)
Mario Menschikowski et al.
Oncotarget (2018)
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Luca Falzone et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy
Juliann E. Kosovec et al.
FRONTIERS IN ONCOLOGY (2018)
Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
Mao Shang et al.
JOURNAL OF CANCER (2018)
Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature
Sonia Khier et al.
FUTURE SCIENCE OA (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast Cancer
Giovanna Rossi et al.
CLINICAL CANCER RESEARCH (2018)
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
Raffaele Palmirotta et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma
Marie-Helene Delfau-Larue et al.
BLOOD ADVANCES (2018)
Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer
Katsutoshi Shoda et al.
GASTRIC CANCER (2017)
Simulating real-life exposures to uncover possible risks to human health: A proposed consensus for a novel methodological approach
A. M. Tsatsakis et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2017)
Nucleosome-free DNA regions differentially affect distant communication in chromatin
Ekaterina V. Nizovtseva et al.
NUCLEIC ACIDS RESEARCH (2017)
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
James A. McCubrey et al.
ONCOTARGET (2017)
Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer
Emil Christensen et al.
EUROPEAN UROLOGY (2017)
Recent advances in circulating tumor cells and cell-free DNA in metastatic prostate cancer: a review
Sunil Parimi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis
Yoshiaki Maru et al.
GYNECOLOGIC ONCOLOGY (2017)
Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid
Meenakshi Mehrotra et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
Joanna Wang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
Liquid biopsy: a step forward towards precision medicine in urologic malignancies
Ashley Di Meo et al.
MOLECULAR CANCER (2017)
Current and Emerging Applications of Droplet Digital PCR in Oncology
Susana Olmedillas-Lopez et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
The risk of HCV infection among health-care workers and its association with extrahepatic manifestations
Adriana Garozzo et al.
MOLECULAR MEDICINE REPORTS (2017)
Absence of t(14;18) chromosome translocation in agricultural workers after short-term exposure to pesticides
Venerando Rapisarda et al.
MOLECULAR MEDICINE REPORTS (2017)
Immunological effects of occupational exposure to lead
Concettina Fenga et al.
MOLECULAR MEDICINE REPORTS (2017)
NF-κB inhibition is associated with OPN/MMP-9 downregulation in cutaneous melanoma
Claudio Guarneri et al.
ONCOLOGY REPORTS (2017)
Intratumor and Intertumor Heterogeneity in Melanoma
Tomasz M. Grzywa et al.
TRANSLATIONAL ONCOLOGY (2017)
Liquid biopsy: unlocking the potentials of cell-free DNA
David Chu et al.
VIRCHOWS ARCHIV (2017)
Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
Shiyu Jia et al.
ONCOTARGET (2017)
Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
Gaowei Fan et al.
ONCOTARGET (2017)
Environment and bladder cancer: molecular analysis by interaction networks
Andrea Polo et al.
ONCOTARGET (2017)
Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma
Ting Xu et al.
THERANOSTICS (2017)
Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
Giuseppe L. Banna et al.
FRONTIERS IN PHARMACOLOGY (2017)
CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function
Hyun Sik Jang et al.
GENES (2017)
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
K. M. Patel et al.
SCIENTIFIC REPORTS (2017)
The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
Sabine Riethdorf et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2017)
Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival
Daniel J. Boffa et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy
Yulian Khagi et al.
CLINICAL CANCER RESEARCH (2017)
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Fanny Garlan et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer
Lone V. Scholer et al.
CLINICAL CANCER RESEARCH (2017)
Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers
Elisa Danese et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
V. Conteduca et al.
ANNALS OF ONCOLOGY (2017)
Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients
Joost H. van Ginkel et al.
BMC CANCER (2017)
Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer
Joseph J. Fantony et al.
CANCER BIOMARKERS (2017)
KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
Yuurin Kondo et al.
BMC CANCER (2017)
Using circulating cell-free DNA to monitor personalized cancer therapy
Michael Oellerich et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Initial diagnosis of chronic myelogenous leukemia based on quantification of M-BCR status using droplet digital PCR
Helen Louise Lund et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer
Antonin Brisuda et al.
UROLOGIA INTERNATIONALIS (2016)
Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study
Sameh Hafsi et al.
ONCOLOGY LETTERS (2016)
An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
Yongqiang Wang et al.
ONCOTARGET (2016)
Genomic and Epigenomic Alterations in Cancer
Balabhadrapatruni V. S. K. Chakravarthi et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Characterization of the cell-free DNA released by cultured cancer cells
Abel Jacobus Bronkhorst et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Origins, structures, and functions of circulating DNA in oncology
A. R. Thierry et al.
CANCER AND METASTASIS REVIEWS (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles
Janine Aucamp et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing
Chiaki Nakauchi et al.
CLINICAL BREAST CANCER (2016)
Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
Liqiang Xi et al.
CLINICAL CANCER RESEARCH (2016)
Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?
Felix Leung et al.
CLINICAL CHEMISTRY (2016)
A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
Sonia Garrigou et al.
CLINICAL CHEMISTRY (2016)
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
Fiona S. Togneri et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
Karin Birkenkamp-Demtroder et al.
EUROPEAN UROLOGY (2016)
New challenges in risk assessment of chemicals when simulating real exposure scenarios; simultaneous multi-chemicals' low dose exposure
Aristidis M. Tsatsakis et al.
FOOD AND CHEMICAL TOXICOLOGY (2016)
Occupational exposure to carcinogens: Benzene, pesticides and fibers
Luca Falzone et al.
MOLECULAR MEDICINE REPORTS (2016)
Clusters of circulating tumor cells traverse capillary-sized vessels
Sam H. Au et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients
Anne Winther-Larsen et al.
TRANSLATIONAL ONCOLOGY (2016)
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
Peiyong Jiang et al.
TRENDS IN GENETICS (2016)
Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells
Venerando Rapisarda et al.
ONCOLOGY LETTERS (2016)
Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing
Eri Kameta et al.
ONCOLOGY LETTERS (2016)
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
Peter Ulz et al.
NATURE COMMUNICATIONS (2016)
Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer
Evelyn Kidess-Sigal et al.
ONCOTARGET (2016)
Alu methylation serves as a biomarker for non-invasive diagnosis of glioma
Jian Chen et al.
ONCOTARGET (2016)
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
Kyung-A Hyun et al.
ONCOTARGET (2016)
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer
Luca Falzone et al.
ONCOTARGET (2016)
Colon Cancer Cells Gene Expression Signature As Response to 5-Fluorouracil, Oxaliplatin, and Folinic Acid Treatment
Carolina Negrei et al.
FRONTIERS IN PHARMACOLOGY (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
Alexander W. Wyatt et al.
JAMA ONCOLOGY (2016)
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
Chiara Nicolazzo et al.
SCIENTIFIC REPORTS (2016)
Cell-free circulating tumor DNA in cancer
Zhen Qin et al.
CHINESE JOURNAL OF CANCER (2016)
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
S. Salvi et al.
BRITISH JOURNAL OF CANCER (2015)
Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
Anna L. Reid et al.
CLINICAL BIOCHEMISTRY (2015)
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
Arun A. Azad et al.
CLINICAL CANCER RESEARCH (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A. Zill et al.
CANCER DISCOVERY (2015)
Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer
Ekkehard Schuetz et al.
CLINICAL CHEMISTRY (2015)
Quantitative Cell-Free Circulating BRAF(V600E) Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
Miguel F. Sanmamed et al.
CLINICAL CHEMISTRY (2015)
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
Jordan Madic et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Richard B. Lanman et al.
PLOS ONE (2015)
SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients
Julia Stadler et al.
PLOS ONE (2015)
Circulating DNA as biomarker in breast cancer
Heidi Schwarzenbach et al.
BREAST CANCER RESEARCH (2015)
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
M. Ignatiadis et al.
ANNALS OF ONCOLOGY (2014)
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F. Rothe et al.
ANNALS OF ONCOLOGY (2014)
The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
A. D. Nygaard et al.
BRITISH JOURNAL OF CANCER (2014)
Reactive Response Evaluation of Primary Human Astrocytes After Methylmercury Exposure
Giuseppe A. Malfa et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Assessment of EGFR Mutations in Circulating Tumor Cell Preparations from NSCLC Patients by Next Generation Sequencing: Toward a Real-Time Liquid Biopsy for Treatment
Antonio Marchetti et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Isolation and Molecular Characterization of Circulating Melanoma Cells
Xi Luo et al.
CELL REPORTS (2014)
The dynamic range of circulating tumor DNA in metastatic breast cancer
Maryam Heidary et al.
BREAST CANCER RESEARCH (2014)
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
Ellen Heitzer et al.
CANCER RESEARCH (2013)
Quantification of plasma cell-free DNA1 in predicting therapeutic efficacy of sorafenib on metastatic clear cell renal cell carcinoma
Gang Feng et al.
DISEASE MARKERS (2013)
Hypermethylation of TWIST1 and NID2 in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients
Zeynep Yegin et al.
DNA AND CELL BIOLOGY (2013)
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Diego M. Marzese et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Absolute quantification by droplet digital PCR versus analog real-time PCR
Christopher M. Hindson et al.
NATURE METHODS (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
Florent Mouliere et al.
TRANSLATIONAL ONCOLOGY (2013)
Monitoring of Plasma Cell-Free DNA in Predicting Postoperative Recurrence of Clear Cell Renal Cell Carcinoma
JingJing Wan et al.
UROLOGIA INTERNATIONALIS (2013)
Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
Valentina Casadio et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
MET amplification as a potential therapeutic target in gastric cancer
Hisato Kawakami et al.
ONCOTARGET (2013)
Alu elements: an intrinsic source of human genome instability
Catherine Ade et al.
CURRENT OPINION IN VIROLOGY (2013)
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Ellen Heitzer et al.
GENOME MEDICINE (2013)
Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma
Joakim Crona et al.
ENDOCRINE CONNECTIONS (2013)
ELIMED: a new hadron therapy concept based on laser driven ion beams
Giuseppe A. P. Cirrone et al.
LASER ACCELERATION OF ELECTRONS, PROTONS, AND IONS II; AND MEDICAL APPLICATIONS OF LASER-GENERATED BEAMS OF PARTICLES II; AND HARNESSING RELATIVISTIC PLASMA WAVES III (2013)
Evaluation of a Droplet Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification
Leonardo B. Pinheiro et al.
ANALYTICAL CHEMISTRY (2012)
Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
K. Sakaizawa et al.
BRITISH JOURNAL OF CANCER (2012)
Global DNA hypomethylation in cancer: review of validated methods and clinical significance
Estela G. Torano et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
Jacqueline A. Shaw et al.
GENOME RESEARCH (2012)
Genome-wide nucleosome positioning during embryonic stem cell development
Vladimir B. Teif et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids
Vaneet K. Sharma et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2011)
Determinants of nucleosome organization in primary human cells
Anton Valouev et al.
NATURE (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Universal noninvasive detection of solid organ transplant rejection
Thomas M. Snyder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors
David J. McBride et al.
GENES CHROMOSOMES & CANCER (2010)
Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
Marc Taenzer et al.
PLOS ONE (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Next Generation DNA Sequencing and the Future of Genomic Medicine
Matthew W. Anderson et al.
GENES (2010)
TP53 R249S Mutations, Exposure to Aflatoxin, and Occurrence of Hepatocellular Carcinoma in a Cohort of Chronic Hepatitis B Virus Carriers from Qidong, China
Katarzyna Szymanska et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples
Isabelle Renard et al.
EUROPEAN UROLOGY (2009)
Introduction: Unknown Primary Cancer
F. Anthony Greco et al.
SEMINARS IN ONCOLOGY (2009)
Next-generation DNA sequencing
Jay Shendure et al.
NATURE BIOTECHNOLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Robert Gruetzmann et al.
PLOS ONE (2008)
Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients
Zhao Hui Huang et al.
CANCER LETTERS (2006)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
DNA alterations in body fluids as molecular tumor markers for urological malignancies
C Goessl et al.
EUROPEAN UROLOGY (2002)
Share Paper
